Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Insulins

Journal articles and book chapters

12-13-2018 | Insulin aspart | Article

Investigating the association between baseline characteristics (HbA1c and body mass index) and clinical outcomes of fast-acting insulin aspart in people with diabetes: A post hoc analysis

Bowering K et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0553-7

11-27-2018 | Insulin | Article

Insulin injection technique questionnaire: Results of an international study comparing Brazil, Latin America and World data

Calliari LE et al. Diabetol Metab Syndr 2018; 10: 85. doi: 10.1186/s13098-018-0389-3

11-15-2018 | Pregnancy | Article

Successful outcomes with insulin degludec in pregnancy: A case series

Hiranput S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0532-z

11-03-2018 | Premixed insulins | Review | Article

Expert opinion: Patient selection for premixed insulin formulations in diabetes care

Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

10-04-2018 | Mobile technology | Review | Article

App-based insulin calculators: Current and future state

Eiland L et al. Curr Diab Rep 2018; 18: 123. doi: 10.1007/s11892-018-1097-y

09-14-2018 | Insulin glargine/Lixisenatide | Article

Bedtime-to-morning glucose difference and iGlarLixi in type 2 diabetes: Post hoc analysis of LixiLan-L

Zisman A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0507-0

09-14-2018 | Psychosocial care | Article

Improved treatment engagement among patients with diabetes treated with insulin glargine 300 U/mL who participated in the COACH support program

Goldman JD et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0501-6

09-13-2018 | Pramlintide acetate | Article

Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadministration of pramlintide and regular human insulin: A randomized, two-way crossover study

Riddle MC et al. Diabetes Care 2018: dc181091. doi: 10.2337/dc18-1091

09-10-2018 | Insulin glargine | Article

Association of patient profile with glycemic control and hypoglycemia with insulin glargine 300 U/mL in type 2 diabetes: A post hoc patient-level meta-analysis

Twigg SM et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0498-x

08-30-2018 | Pregnancy | Article

Long-term effects of oral antidiabetic drugs during pregnancy on offspring: A systematic review and meta-analysis of follow-up studies of RCTs

van Weelden W et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0479-0

08-29-2018 | Hypoglycemia | Article

A post hoc pooled analysis to evaluate hypoglycemia risk with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in people with type 2 diabetes on a basal‐only insulin regimen

Bolli GB et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13515

08-21-2018 | Dulaglutide | Article

Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulfonylurea: A 52‐week open‐label, randomized phase 3 trial

Wang W et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13506

08-20-2018 | Insulin pumps | Article

Real‐world outcomes of insulin pump compared to injection therapy in a population based sample of children with type 1 diabetes

Burckhardt MA et al. Pediatr Diabetes 2018. doi: 10.1111/pedi.12754

08-18-2018 | Continuous glucose monitoring | Review | Article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

08-17-2018 | Medications | Review | Article

Adjuvant pharmacotherapies to insulin for the treatment of type 1 diabetes

Tosur M, Redondo MJ, Lyons SK. Curr Diab Rep 2018; 18: 79. doi: 10.1007/s11892-018-1041-1

08-16-2018 | Pregnancy | Review | Article

Glucose targets and insulin choice in pregnancy: What has changed in the last decade?

Bacon S, Feig DS. Curr Diab Rep 2018; 18: 77. doi: 10.1007/s11892-018-1054-9

08-16-2018 | DPP-4 inhibitors | Review | Article

Safety and efficacy of DPP4 inhibitor and basal insulin in type 2 diabetes: An updated review and challenging clinical scenarios

Gomez-Peralta F et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0488-z

08-15-2018 | Insulin glargine | Article

Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase 3 INSTRIDE 2 study

Blevins TC et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13495

08-15-2018 | Nephropathy | Review | Article

Inpatient glycemic management in the setting of renal insufficiency/failure/dialysis

Iyengar R, Franzese J, Gianchandani R. Curr Diab Rep 2018; 18: 75. doi: 10.1007/s11892-018-1044-y

08-15-2018 | Type 2 diabetes | Article

Time to treatment intensification after monotherapy failure and its association with subsequent glycemic control among 93,515 patients with type 2 diabetes

Desai U et al. Diabetes Care 2018: dc170662. doi: 10.2337/dc17-0662

Next
Image Credits